The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global CD147 Antibody Market Research Report 2025
Synopsis
Global CD147 Antibody market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole CD147 Antibody market research.
Key manufacturers engaged in the CD147 Antibody industry include BosterBio, Bioss, BD Biosciences, GeneTex, RayBiotech, Bio-Rad, NSJ Bioreagents, BioLegend and Abcam, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of CD147 Antibody were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole CD147 Antibody market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global CD147 Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
BosterBio
Bioss
BD Biosciences
GeneTex
RayBiotech
Bio-Rad
NSJ Bioreagents
BioLegend
Abcam
Cell Sciences
LifeSpan BioSciences
Bethyl Laboratories
HUABIO
Thermo Fisher Scientific
Novus Biologicals
Elabscience Biotechnology
R&D Systems
Miltenyi Biotec
Biobyt
Jingjie PTM BioLab
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The CD147 Antibody report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Global CD147 Antibody market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole CD147 Antibody market research.
Key manufacturers engaged in the CD147 Antibody industry include BosterBio, Bioss, BD Biosciences, GeneTex, RayBiotech, Bio-Rad, NSJ Bioreagents, BioLegend and Abcam, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of CD147 Antibody were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole CD147 Antibody market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global CD147 Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
BosterBio
Bioss
BD Biosciences
GeneTex
RayBiotech
Bio-Rad
NSJ Bioreagents
BioLegend
Abcam
Cell Sciences
LifeSpan BioSciences
Bethyl Laboratories
HUABIO
Thermo Fisher Scientific
Novus Biologicals
Elabscience Biotechnology
R&D Systems
Miltenyi Biotec
Biobyt
Jingjie PTM BioLab
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The CD147 Antibody report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 CD147 Antibody Market Overview
1.1 Product Overview and Scope of CD147 Antibody
1.2 CD147 Antibody Segment by Type
1.2.1 Global CD147 Antibody Market Value Comparison by Type (2023-2029)
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 CD147 Antibody Segment by Application
1.3.1 Global CD147 Antibody Market Value by Application: (2023-2029)
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Global CD147 Antibody Market Size Estimates and Forecasts
1.4.1 Global CD147 Antibody Revenue 2018-2029
1.4.2 Global CD147 Antibody Sales 2018-2029
1.4.3 Global CD147 Antibody Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 CD147 Antibody Market Competition by Manufacturers
2.1 Global CD147 Antibody Sales Market Share by Manufacturers (2018-2023)
2.2 Global CD147 Antibody Revenue Market Share by Manufacturers (2018-2023)
2.3 Global CD147 Antibody Average Price by Manufacturers (2018-2023)
2.4 Global CD147 Antibody Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of CD147 Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of CD147 Antibody, Product Type & Application
2.7 CD147 Antibody Market Competitive Situation and Trends
2.7.1 CD147 Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest CD147 Antibody Players Market Share by Revenue
2.7.3 Global CD147 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 CD147 Antibody Retrospective Market Scenario by Region
3.1 Global CD147 Antibody Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global CD147 Antibody Global CD147 Antibody Sales by Region: 2018-2029
3.2.1 Global CD147 Antibody Sales by Region: 2018-2023
3.2.2 Global CD147 Antibody Sales by Region: 2024-2029
3.3 Global CD147 Antibody Global CD147 Antibody Revenue by Region: 2018-2029
3.3.1 Global CD147 Antibody Revenue by Region: 2018-2023
3.3.2 Global CD147 Antibody Revenue by Region: 2024-2029
3.4 North America CD147 Antibody Market Facts & Figures by Country
3.4.1 North America CD147 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America CD147 Antibody Sales by Country (2018-2029)
3.4.3 North America CD147 Antibody Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe CD147 Antibody Market Facts & Figures by Country
3.5.1 Europe CD147 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe CD147 Antibody Sales by Country (2018-2029)
3.5.3 Europe CD147 Antibody Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CD147 Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific CD147 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific CD147 Antibody Sales by Country (2018-2029)
3.6.3 Asia Pacific CD147 Antibody Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America CD147 Antibody Market Facts & Figures by Country
3.7.1 Latin America CD147 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America CD147 Antibody Sales by Country (2018-2029)
3.7.3 Latin America CD147 Antibody Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa CD147 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa CD147 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa CD147 Antibody Sales by Country (2018-2029)
3.8.3 Middle East and Africa CD147 Antibody Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global CD147 Antibody Sales by Type (2018-2029)
4.1.1 Global CD147 Antibody Sales by Type (2018-2023)
4.1.2 Global CD147 Antibody Sales by Type (2024-2029)
4.1.3 Global CD147 Antibody Sales Market Share by Type (2018-2029)
4.2 Global CD147 Antibody Revenue by Type (2018-2029)
4.2.1 Global CD147 Antibody Revenue by Type (2018-2023)
4.2.2 Global CD147 Antibody Revenue by Type (2024-2029)
4.2.3 Global CD147 Antibody Revenue Market Share by Type (2018-2029)
4.3 Global CD147 Antibody Price by Type (2018-2029)
5 Segment by Application
5.1 Global CD147 Antibody Sales by Application (2018-2029)
5.1.1 Global CD147 Antibody Sales by Application (2018-2023)
5.1.2 Global CD147 Antibody Sales by Application (2024-2029)
5.1.3 Global CD147 Antibody Sales Market Share by Application (2018-2029)
5.2 Global CD147 Antibody Revenue by Application (2018-2029)
5.2.1 Global CD147 Antibody Revenue by Application (2018-2023)
5.2.2 Global CD147 Antibody Revenue by Application (2024-2029)
5.2.3 Global CD147 Antibody Revenue Market Share by Application (2018-2029)
5.3 Global CD147 Antibody Price by Application (2018-2029)
6 Key Companies Profiled
6.1 BosterBio
6.1.1 BosterBio Corporation Information
6.1.2 BosterBio Description and Business Overview
6.1.3 BosterBio CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.1.4 BosterBio CD147 Antibody Product Portfolio
6.1.5 BosterBio Recent Developments/Updates
6.2 Bioss
6.2.1 Bioss Corporation Information
6.2.2 Bioss Description and Business Overview
6.2.3 Bioss CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bioss CD147 Antibody Product Portfolio
6.2.5 Bioss Recent Developments/Updates
6.3 BD Biosciences
6.3.1 BD Biosciences Corporation Information
6.3.2 BD Biosciences Description and Business Overview
6.3.3 BD Biosciences CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.3.4 BD Biosciences CD147 Antibody Product Portfolio
6.3.5 BD Biosciences Recent Developments/Updates
6.4 GeneTex
6.4.1 GeneTex Corporation Information
6.4.2 GeneTex Description and Business Overview
6.4.3 GeneTex CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GeneTex CD147 Antibody Product Portfolio
6.4.5 GeneTex Recent Developments/Updates
6.5 RayBiotech
6.5.1 RayBiotech Corporation Information
6.5.2 RayBiotech Description and Business Overview
6.5.3 RayBiotech CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.5.4 RayBiotech CD147 Antibody Product Portfolio
6.5.5 RayBiotech Recent Developments/Updates
6.6 Bio-Rad
6.6.1 Bio-Rad Corporation Information
6.6.2 Bio-Rad Description and Business Overview
6.6.3 Bio-Rad CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Bio-Rad CD147 Antibody Product Portfolio
6.6.5 Bio-Rad Recent Developments/Updates
6.7 NSJ Bioreagents
6.6.1 NSJ Bioreagents Corporation Information
6.6.2 NSJ Bioreagents Description and Business Overview
6.6.3 NSJ Bioreagents CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.4.4 NSJ Bioreagents CD147 Antibody Product Portfolio
6.7.5 NSJ Bioreagents Recent Developments/Updates
6.8 BioLegend
6.8.1 BioLegend Corporation Information
6.8.2 BioLegend Description and Business Overview
6.8.3 BioLegend CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.8.4 BioLegend CD147 Antibody Product Portfolio
6.8.5 BioLegend Recent Developments/Updates
6.9 Abcam
6.9.1 Abcam Corporation Information
6.9.2 Abcam Description and Business Overview
6.9.3 Abcam CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Abcam CD147 Antibody Product Portfolio
6.9.5 Abcam Recent Developments/Updates
6.10 Cell Sciences
6.10.1 Cell Sciences Corporation Information
6.10.2 Cell Sciences Description and Business Overview
6.10.3 Cell Sciences CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Cell Sciences CD147 Antibody Product Portfolio
6.10.5 Cell Sciences Recent Developments/Updates
6.11 LifeSpan BioSciences
6.11.1 LifeSpan BioSciences Corporation Information
6.11.2 LifeSpan BioSciences CD147 Antibody Description and Business Overview
6.11.3 LifeSpan BioSciences CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.11.4 LifeSpan BioSciences CD147 Antibody Product Portfolio
6.11.5 LifeSpan BioSciences Recent Developments/Updates
6.12 Bethyl Laboratories
6.12.1 Bethyl Laboratories Corporation Information
6.12.2 Bethyl Laboratories CD147 Antibody Description and Business Overview
6.12.3 Bethyl Laboratories CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Bethyl Laboratories CD147 Antibody Product Portfolio
6.12.5 Bethyl Laboratories Recent Developments/Updates
6.13 HUABIO
6.13.1 HUABIO Corporation Information
6.13.2 HUABIO CD147 Antibody Description and Business Overview
6.13.3 HUABIO CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.13.4 HUABIO CD147 Antibody Product Portfolio
6.13.5 HUABIO Recent Developments/Updates
6.14 Thermo Fisher Scientific
6.14.1 Thermo Fisher Scientific Corporation Information
6.14.2 Thermo Fisher Scientific CD147 Antibody Description and Business Overview
6.14.3 Thermo Fisher Scientific CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Thermo Fisher Scientific CD147 Antibody Product Portfolio
6.14.5 Thermo Fisher Scientific Recent Developments/Updates
6.15 Novus Biologicals
6.15.1 Novus Biologicals Corporation Information
6.15.2 Novus Biologicals CD147 Antibody Description and Business Overview
6.15.3 Novus Biologicals CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Novus Biologicals CD147 Antibody Product Portfolio
6.15.5 Novus Biologicals Recent Developments/Updates
6.16 Elabscience Biotechnology
6.16.1 Elabscience Biotechnology Corporation Information
6.16.2 Elabscience Biotechnology CD147 Antibody Description and Business Overview
6.16.3 Elabscience Biotechnology CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Elabscience Biotechnology CD147 Antibody Product Portfolio
6.16.5 Elabscience Biotechnology Recent Developments/Updates
6.17 R&D Systems
6.17.1 R&D Systems Corporation Information
6.17.2 R&D Systems CD147 Antibody Description and Business Overview
6.17.3 R&D Systems CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.17.4 R&D Systems CD147 Antibody Product Portfolio
6.17.5 R&D Systems Recent Developments/Updates
6.18 Miltenyi Biotec
6.18.1 Miltenyi Biotec Corporation Information
6.18.2 Miltenyi Biotec CD147 Antibody Description and Business Overview
6.18.3 Miltenyi Biotec CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Miltenyi Biotec CD147 Antibody Product Portfolio
6.18.5 Miltenyi Biotec Recent Developments/Updates
6.19 Biobyt
6.19.1 Biobyt Corporation Information
6.19.2 Biobyt CD147 Antibody Description and Business Overview
6.19.3 Biobyt CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Biobyt CD147 Antibody Product Portfolio
6.19.5 Biobyt Recent Developments/Updates
6.20 Jingjie PTM BioLab
6.20.1 Jingjie PTM BioLab Corporation Information
6.20.2 Jingjie PTM BioLab CD147 Antibody Description and Business Overview
6.20.3 Jingjie PTM BioLab CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Jingjie PTM BioLab CD147 Antibody Product Portfolio
6.20.5 Jingjie PTM BioLab Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CD147 Antibody Industry Chain Analysis
7.2 CD147 Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CD147 Antibody Production Mode & Process
7.4 CD147 Antibody Sales and Marketing
7.4.1 CD147 Antibody Sales Channels
7.4.2 CD147 Antibody Distributors
7.5 CD147 Antibody Customers
8 CD147 Antibody Market Dynamics
8.1 CD147 Antibody Industry Trends
8.2 CD147 Antibody Market Drivers
8.3 CD147 Antibody Market Challenges
8.4 CD147 Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
